Other languages Isofol Medical AB

Equities

Delayed Nasdaq Stockholm Other stock markets 06:20:49 29/04/2024 pm IST			5-day change	1st Jan Change
0.735 ^SEK	+5.91%		+2.23%	+0.68%

20/02	Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
20/02	Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20/02
Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	20/02
Isofol Medical Hires New CFO	11/01
Isofol Medical Names New CEO	09/01
Isofol Medical AB Announces CEO Changes	09/01
Isofol Medical AB Announces Board Elections	04/01
Isofol Medical AB Presents Additional Results from Laboratory Tests with Arfolitixorin Showing Supplementary Effects	29/12
Isofol Medical AB Appoints Jan-Eric Österlund as Member of the Board	13/12
Isofol Receives the First Results from Laboratory Tests of Arfolitixorin	08/12
Isofol Medical Unit to Face Liquidation	01/12
Isofol Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
Isofol Receives Shareholders Request for EGM; Shares Fall	09/11
Isofol Medical AB Announces Appointment of Nomination Committee Members	08/11
Isofol Medical AB Announces Results from the Modelle 001 Study	05/23/05
Isofol Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/23/22
Isofol Medical AB Presents Conclusions from the In-Depth Analysis of the AGENT Study	04/23/04
Sweden's Isofol Medical Names Acting CEO	23/23/23
Isofol Medical AB Appoints Roger Tell as Acting CEO	22/23/22
Isofol Medical CEO Steps Down	22/23/22
Isofol Medical AB Announces Resignation of Thomas Andersson as CEO	21/23/21

No results for this search